Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.
建立组件的工业化生产,使癌症患者群体能够更容易地获得 PET 成像。
基本信息
- 批准号:10698218
- 负责人:
- 金额:$ 15.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcetonitrilesAchievementAddressAliquotAutomationBiological AssayBusinessesCancer PatientClinicColorContrast MediaData AnalysesDeoxyglucoseDevelopmentDevicesEndotoxinsEnsureEquipmentEthanolFreezingHalf-LifeHealthIndustryInjectionsMalignant NeoplasmsManualsManufacturerMeasurementMethodsMoldsMolecularOncologyOpticsPatientsPerformancePharmaceutical PreparationsPhasePositioning AttributePositron-Emission TomographyProblem SolvingProceduresProcessProductionQuality ControlRadioactiveRadioactivityReaderRecordsRecurrenceReportingRiskSamplingSiteSystemTechnologyTestingTracerValidationVisualWorkbasecancer typeclinical imagingcomparativecostdesigndrug qualityhigh riskimaging modalityindustrial productioninnovationmanufacturemanufacturing processmanufacturing scale-upmanufacturing technologynew technologyoperationpatient populationscale upskillsstandard of caretooltumorvalidation studies
项目摘要
CRP Technical assistance is intended to accomplish the following for Tracer-QC product under development.
It will establish industrial production methods (specifically high-precision injection molding) necessary to ensure consistent
and controlled scale-up manufacturing of Tracer-QC analysis plates that are currently manufactured by non-salable, variable
and costly machining process.
CRP Problem. Trace-Ability is focusing a lot of current effort on scaling up Tracer-QC kit production to the levels
that can supply the entire PET industry with high-quality kits. However, there is one aspect where the current manufacturing
technology is not scalable and carries quality risks. It needs to be replaced by a completely new technology in order to
support the PET industry. Specifically, it is the manufacturing of the core Tracer-QC analysis plate in which all QC
assessments take place. Current plates are made by cutting standard 384-well plates. Such process is not scalable. It has
inherent plate-to-plate variability and a high risk of debris contaminating the wells required for precise optical analysis.
CRP Solution. Trace-Ability has developed a proposal together with Agilent Technologies, Inc. to manufacture
analysis plates by injection molding. This project is designed to establish scalable production of analysis plates and re-
validate all existing Tracer-QC assays in these plates.
Specific Aim 1: Scalable injection molding process for manufacturing high-quality analysis plates. The “high-quality”
acceptance criteria are (a) well absorbance <0.065 AU in the range of 400-700 nm with a standard deviation (b) <0.003 AU
in empty wells and (c) <1% in filled wells at 500 nm. Development will be performed by Agilent. Milestones: (a) Molded
plates meet all acceptance criteria. (b) Finalized molding process is suitable for over 200,000 plates per year.
Specific Aim 2: Tracer-QC tests validated successfully in molded plates. Before the new plates can be included in
Tracer-QC kits that can be used for release testing of FDG and other PET drugs, 8 assays that rely on the wells of the plate
will require testing and validation: color, clarity, pH, Endotoxin, Kryptofix, acetonitrile, ethanol and radioactivity
concentration. Proposed work will be carried out at Trace-Ability. Milestone: Validation results meet all ICH Q2 (R1)
acceptance criteria for all assays.
This proposal is for technical assistance associated with manufacturing, including industrial production equipment and
methods necessary to ensure consistent and controlled scale-up manufacturing according to recognized quality standards.
Achievement of the above aims will put Trace-Ability in position to support all manufacturers of cancer PET drugs in their
full capacity with a fully-automated QC solution. This will maximize the commercial potential of the Tracer-QC business
that relies on recurring kit revenues from the growing install base. The impact in the field of Oncology will be manifested
in increased availability of FDG and other cancer PET scans and facilitation of new tracer development. Such availability
is currently limited by throughput and compliance issues in PET drug QC, which Tracer-QC has proven to address
successfully, but needs scalable kit production to offer the enabling benefits to the entire industry.
CRP技术援助旨在为开发中的Tracer-QC产品完成以下工作。
它将建立必要的工业生产方法(特别是高精度注塑成型),以确保一致性
和Tracer-QC分析板的受控规模化生产,这些分析板目前由不可销售的可变
和昂贵的加工工艺。
CRP问题。Trace-Ability目前正集中精力将Tracer-QC试剂盒的生产规模扩大到
可以为整个PET行业提供高质量的套件。然而,有一个方面,目前的制造业
技术不具有可扩展性,并存在质量风险。它需要被一种全新的技术所取代,
支持PET行业。具体而言,它是核心Tracer-QC分析板的制造,其中所有QC
进行评估。当前板通过切割标准384孔板来制备。这样的过程是不可扩展的。它有
固有的板与板的可变性和碎片污染精确光学分析所需的威尔斯孔的高风险。
CRP溶液。Trace-Ability与安捷伦科技公司(Agilent Technologies,Inc.)制造
分析板通过注射成型。该项目旨在建立可扩展的分析板生产和再生产,
确认这些平板中所有现有的Tracer-QC检测试剂盒。
具体目标1:用于制造高质量分析板的可扩展注塑工艺。“高质量”
验收标准为(a)在400-700 nm范围内孔吸光度<0.065 Au,标准偏差(B)<0.003 Au
在空威尔斯孔中,和(c)在填充的威尔斯孔中,在500 nm处<1%。将由Agilent进行开发。Milestone:(a)Molded
平板符合所有验收标准。(b)最终成型工艺适用于每年超过200,000个板。
具体目标2:在模塑板中成功确认Tracer-QC试验。在新的板块可以包括在
可用于FDG和其他PET药物放行检测的Tracer-QC试剂盒,8项检测依赖于平板的威尔斯孔
需要检测和验证:颜色、澄清度、pH值、内毒素、Kryptofix、乙腈、乙醇和放射性
浓度.拟议工作将在Trace-Ability进行。里程碑:验证结果符合所有ICH Q2(R1)
所有试验的验收标准。
本提案涉及与制造业有关的技术援助,包括工业生产设备,
根据公认的质量标准,确保一致和受控的规模扩大生产所必需的方法。
上述目标的实现将使Trace-Ability能够支持所有癌症PET药物制造商,
提供全自动QC解决方案。这将最大限度地发挥Tracer-QC业务的商业潜力
这依赖于不断增长的安装基础带来的经常性套件收入。在肿瘤学领域的影响将得到体现
FDG和其他癌症PET扫描的可用性增加,并促进新示踪剂的开发。这样的可用性
目前受到PET药物QC中的通量和合规性问题的限制,Tracer-QC已被证明可以解决这些问题
成功,但需要可扩展的套件生产,以提供整个行业的有利条件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arkadij Elizarov其他文献
Arkadij Elizarov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arkadij Elizarov', 18)}}的其他基金
Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
通过在 AD PET 示踪剂的商业生产中采用彻底简化和标准化的质量控制,使全国范围内的 AD PET 成像能够支持最有效的临床试验。
- 批准号:
10156578 - 财政年份:2021
- 资助金额:
$ 15.62万 - 项目类别:
Rapid pre-release sterility test for PET Drugs.
PET 药物的快速发布前无菌测试。
- 批准号:
10258453 - 财政年份:2021
- 资助金额:
$ 15.62万 - 项目类别:
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.
在 PET 放射性药品制造行业广泛实施质量控制现代化通用解决方案。
- 批准号:
10452538 - 财政年份:2020
- 资助金额:
$ 15.62万 - 项目类别:
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.
在 PET 放射性药品制造行业广泛实施质量控制现代化通用解决方案。
- 批准号:
10675471 - 财政年份:2020
- 资助金额:
$ 15.62万 - 项目类别:
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.
在 PET 放射性药品制造行业广泛实施质量控制现代化通用解决方案。
- 批准号:
10245060 - 财政年份:2020
- 资助金额:
$ 15.62万 - 项目类别:
Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients.
为 4 种 PET 成像示踪剂开发完全自动化的质量控制程序,这将提高生产量并扩大患者可用的 PET 成像的多样性。
- 批准号:
9797682 - 财政年份:2018
- 资助金额:
$ 15.62万 - 项目类别:
Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology.
通过实施自动释放测试技术来减轻放射性药物生产中的质量和合规风险。
- 批准号:
9102704 - 财政年份:2015
- 资助金额:
$ 15.62万 - 项目类别:
Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology.
通过实施自动释放测试技术来减轻放射性药物生产中的质量和合规风险。
- 批准号:
9338051 - 财政年份:2015
- 资助金额:
$ 15.62万 - 项目类别:
Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG
癌症 PET 成像示踪剂 - [F-18]FDG 自动化质量控制的分析方法
- 批准号:
9255787 - 财政年份:2015
- 资助金额:
$ 15.62万 - 项目类别:
相似海外基金
Collaborative Research: Using Adaptive Lessons to Enhance Motivation, Cognitive Engagement, And Achievement Through Equitable Classroom Preparation
协作研究:通过公平的课堂准备,利用适应性课程来增强动机、认知参与和成就
- 批准号:
2335802 - 财政年份:2024
- 资助金额:
$ 15.62万 - 项目类别:
Standard Grant
Collaborative Research: Using Adaptive Lessons to Enhance Motivation, Cognitive Engagement, And Achievement Through Equitable Classroom Preparation
协作研究:通过公平的课堂准备,利用适应性课程来增强动机、认知参与和成就
- 批准号:
2335801 - 财政年份:2024
- 资助金额:
$ 15.62万 - 项目类别:
Standard Grant
A Longitudinal Study of the Relationship between Participation in a Comprehensive Exercise Program and Academic Achievement
参加综合锻炼计划与学业成绩之间关系的纵向研究
- 批准号:
24K14615 - 财政年份:2024
- 资助金额:
$ 15.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Collaborative Research: Characterizing Best Practices of Instructors who Have Narrowed Performance Gaps in Undergraduate Student Achievement in Introductory STEM Courses
合作研究:缩小本科生 STEM 入门课程成绩差距的讲师的最佳实践
- 批准号:
2420369 - 财政年份:2024
- 资助金额:
$ 15.62万 - 项目类别:
Standard Grant
Collaborative Research: Using Adaptive Lessons to Enhance Motivation, Cognitive Engagement, And Achievement Through Equitable Classroom Preparation
协作研究:通过公平的课堂准备,利用适应性课程来增强动机、认知参与和成就
- 批准号:
2335800 - 财政年份:2024
- 资助金额:
$ 15.62万 - 项目类别:
Standard Grant
WTG: Diffusion of Research on Supporting Mathematics Achievement for Youth with Disabilities through Twitter Translational Visual Abstracts
WTG:通过 Twitter 翻译视觉摘要传播支持残疾青少年数学成就的研究
- 批准号:
2244734 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
Standard Grant
The Impact of Emotional Experiences of Pride on Long-Term Goal Achievement Behaviors in Elite Athletes
骄傲的情感体验对优秀运动员长期目标实现行为的影响
- 批准号:
23K16740 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Meta-Analysis of the Instructional-Relational Model of Student Engagement and Math Achievement: A Moderation and Mediation Approach
学生参与度和数学成绩的教学关系模型的元分析:一种调节和中介方法
- 批准号:
2300738 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
Standard Grant
Improving maths achievement in children with speech, language, and communication needs through 'collaborative vocabulary teaching'
通过“协作词汇教学”提高有言语、语言和交流需求的儿童的数学成绩
- 批准号:
2890475 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
Studentship
HSI Institutional Transformation Project: Retention and Achievement for Introductory STEM English Learners (RAISE)
HSI 机构转型项目:STEM 英语入门学习者的保留和成就 (RAISE)
- 批准号:
2225178 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
Continuing Grant